Immune Checkpoint Blockade Therapy for Breast Cancer: Lessons from Epithelial–Mesenchymal Transition

Immune checkpoint blockade therapies have generated efficacious responses in certain tumor types; however, the responses of breast carcinomas have been largely limited. Moreover, the identity of various parameters that can predict responses to immunotherapies, and at the same time, serve as putative...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Connell, Isabel, Dongre, Anushka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299941/
https://www.ncbi.nlm.nih.gov/pubmed/37193859
http://dx.doi.org/10.1007/s40291-023-00652-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299941/
https://www.ncbi.nlm.nih.gov/pubmed/37193859
http://dx.doi.org/10.1007/s40291-023-00652-3

Ejemplares similares